News from NYU Langone Health
Crain's New York Business
A new generation of leaders is taking over at New York City's largest hospital systems amid significant financial and regulatory challenges. In the last two years, NYU Langone, New York-Presbyterian, and Northwell Health have all announced CEO replacements for their long-tenured executives. This follows the 2023 leadership change at Mount Sinai Health System. The new CEOs, all promoted from within and with physician backgrounds, face federal funding cuts but see an opportunity to innovate. At NYU Langone, new CEO Alec Kimmelman, MD, PhD, will leverage AI and big data, while Northwell Health's new leader, Dr. John D’Angelo, is focused on digital transformation.
11/07/2025
Becker's Hospital Review
NYU Langone Health launched 'Care on Demand' walk-in primary care services in Manhattan in August 2024, expanding access and introducing new patients to its system. Andrew Rubin, senior vice president for clinical affairs and ambulatory care at NYU Langone Health, noted the sites' success in volume and patient acquisition. Between one-third and half of daily patients are new to NYU Langone Health, receiving referrals for further care within the system. This model addresses rising primary care demand and long wait times, aligning with an industry focus on timely access to appropriate care.
11/10/2025
Fox News
A study co-authored by researchers at NYU Langone Health and other institutions reveals chronic kidney disease is now the ninth leading cause of global death, with cases surging from 378 million to 788 million between 1990 and 2023. Josef Coresh, MD, PhD, the Terry and Mel Karmazin Professor of Population Health, Department of Population Health and director of NYU Langone’s Optimal Aging Institute, highlighted the condition as a major public health issue. Morgan Grams, MD, PhD, the Susan and Morris Mark Professor of Medicine at the NYU Grossman School of Medicine and co-director of Division of Precision Medicine, emphasized the need for early detection through urine testing and accessible therapy.
11/10/2025
Becker's Spine Review
The article explores the shift in orthopedics from treatment to prevention, with ten industry leaders sharing insights. Joseph Zuckerman, MD, Walter A.L. Thompson Professor of Orthopedic Surgery and chair of Orthopedic Surgery at NYU Langone Health, emphasizes the need for orthopedic clinicians to partner with basic scientists. This 'dyad' model is crucial for developing preventive treatments that can alter disease trajectories. Other experts discuss integrating technology, new care models, data-driven programs, and early recognition of osteoarthritis to keep patients healthier longer. The focus is on proactive care and incentivizing prevention.
11/10/2025
Natural News
Research reveals a specific oral bacteria strain, Fusobacterium nucleatum animalis C2, actively drives colorectal cancer growth. Separately, NYU Langone Health research links oral microbes to pancreatic cancer risk. Jiyoung Ahn, PhD, director of the Epidemiology and Cancer Control Program at Laura and Isaac Perlmutter Cancer Center, associate director for population research at Laura and Isaac Perlmutter Cancer Center and professor in the departments of population health and medicine at NYU Grossman School of Medicine, co-senior author of the pancreatic cancer study, noted the potential for screening via oral profiling. Richard Hayes, DDS, MPH, PhD, professor at the Department of Population Health at NYU Grossman School of Medicine, a senior author on the pancreatic cancer study, emphasized oral hygiene's role in preventing periodontal disease and cancer. These findings suggest a paradigm shift in cancer prevention and early detection.
11/10/2025
Heavy
The Philadelphia 76ers provided an update on Paul George's return from offseason knee surgery. George underwent the procedure at the NYU–Langone Sports Medicine Orthopedic Center, performed by Jonathan L. Glashow, MD, clinical associate professor at the Department of Orthopedic Surgery at NYU Grossman School of Medicine. Coach Nick Nurse indicated George is meeting with his surgeon this weekend, a potential final step before his season debut. The Sixers are currently 6-4, and Nurse expects George to contribute significantly on defense upon his return.
11/10/2025
NBC News
In response to the FDA's decision to remove the black box warning from hormone replacement therapy, Samantha Dunham, MD, clinical associate professor at Department of Obstetrics and Gynecology at NYU Grossman School of Medicine and co-director of Center for Midlife Health and Menopause, offered a cautious and reassuring perspective. Dunham stated that HRT is "not a panacea" and emphasized that effective alternatives exist for menopause symptoms, such as cognitive therapy and non-hormonal medications. She reassured patients, saying they "will not die sooner if they don’t take hormones." Furthermore, she noted that despite claims of other benefits, there is a lack of long-term studies to prove that hormone therapies improve heart health.
11/09/2025
TCTMD
The PISCES trial demonstrated that fish oil supplements nearly halved serious cardiovascular events in hemodialysis patients. Lead author Charmaine Lok, MD, highlighted the high dose and purity of omega-3s. In an accompanying editorial, David Charytan, MD, Norman S. Wikler Professor of Medicine and director of the Division of Nephrology at the NYU Grossman School of Medicine, expressed bafflement at these 'remarkable results,' questioning how the intervention could be so effective when many others have failed. However, he warned that historically, “outsized results of early trials have failed to be replicated”.
11/10/2025
CURE Magazine
Following the 2025 European Society for Medical Oncology Annual Congress, Joshua Sabari, MD, assistant professor in the Department of Medicine at NYU Grossman School of Medicine, and director of High Reliability Organization Initiatives at Perlmutter Cancer Center, joined experts to discuss bladder cancer advances. The panel highlighted promising results from the EV-303 (Keynote 905) trial, which evaluated perioperative therapy with Padcev and Keytruda for muscle-invasive bladder cancer. Experts emphasized the potential of modern therapies to significantly improve patient outcomes and the importance of ongoing research to optimize treatment sequencing and tolerability.
11/10/2025
SurvivorNet
Montessa Lee, a 47-year-old small-cell lung cancer survivor, shares her 19-year journey and advocacy for research. The article highlights the role of faith in coping with cancer and addresses mental health challenges. Asher Aladjem, MD, clinical associate professor at the departments of psychiatry and population health at NYU Grossman School of Medicine, explains that anxiety is a normal protective symptom for cancer patients, emphasizing the importance of treating it for effective treatment completion. He encourages patients to advocate for mental health services. Lee also discusses the rapid advancements in small-cell lung cancer treatments.
11/09/2025
The New York Times
A new federal law will cap student loans for medical school at a level far below the actual cost of attendance. This policy threatens to push lower-income and rural students out of medicine, worsening physician shortages and health inequality. To make medical education more affordable, the author proposes shortening it from four years to three. The argument is that the current model is outdated, and the final year often functions as a costly "gap year" with non-essential training. A three-year curriculum would be a pragmatic solution to counteract the new loan caps.
11/09/2025
HMP Global Learning Network
Janice Mehnert, MD, associate director of Clinical Research, Perlmutter Cancer Center, and director of Melanoma Medical Oncology Program at NYU Langone Health, discussed phase 3 STAMP trial results for pembrolizumab in resected Merkel cell carcinoma. The study demonstrated that adjuvant pembrolizumab significantly reduced the risk of distant metastasis and showed a numerical improvement in relapse-free survival. These findings suggest pembrolizumab may help delay recurrence and disease spread in this aggressive skin cancer. The results were presented at the 2025 European Society for Medical Oncology Congress.
11/10/2025
Prevention
The article explores 'Ozempic face,' a term describing facial volume loss and accelerated aging linked to rapid weight loss from semaglutide medications like Ozempic. Priya Jaisinghani, MD, endocrinologist and obesity medicine specialist at NYU Langone Health, clinical assistant professor at NYU Grossman School of Medicine, explains that this effect is particularly noticeable with significant, rapid weight loss. Experts note that any substantial weight loss can lead to a gaunt facial appearance as fat diminishes. While not a medical term, 'Ozempic face' highlights a common side effect of weight loss, with management options including dosage adjustments, dietary protein, and cosmetic interventions.
11/10/2025
Radiology Business
Siemens Healthineers and NYU Langone Health have formed a strategic five-year, $100 million agreement to enhance NYU Langone Health's imaging services across Manhattan, Brooklyn, and Long Island. Siemens will supply advanced diagnostic imaging equipment, including MRI, CT, and X-ray machines, to over 300 outpatient and hospital locations. The deal also includes an integrated service agreement for equipment operations. Michael P. Recht, MD, the Louis Marx Professor of Radiology and chair of the department of radiology at NYU Langone Health, expressed optimism that the renewed partnership will maximize productivity and improve patient care.
11/09/2025
Everyday Health
A new experimental obesity drug, eloralintide, is moving into late-stage clinical trials after mid-stage results showed participants lost up to 20 percent of their body weight over 48 weeks. Unlike GLP-1 medicines, eloralintide mimics the pancreatic hormone amylin. Melanie Jay, MD, professor of population health at NYU Langone Health and director of the NYU Langone Comprehensive Program on Obesity, noted that while long-term data is pending, the weight loss rate appears similar to tirzepatide. She emphasized the importance of resistance training to mitigate muscle mass loss with rapid weight loss.
11/09/2025
Medical Xpress
Findings from the TUXEDO-2 study, presented at the American Heart Association's Scientific Sessions 2025, indicate that prasugrel may be a better antiplatelet choice than ticagrelor for people with diabetes who have received drug-eluting stents. Sripal Bangalore, MD, MHA, FAHA, professor of medicine at NYU Grossman School of Medicine and director of Cardiac Catheterization Laboratory, noted that the medications should not be considered interchangeable. The study observed lower rates of heart attack, stroke, bleeding complications, or death in the prasugrel group over one year.
11/09/2025
Archyde
A new study co-led by researchers at UT Health San Antonio and NYU Grossman School of Medicine suggests a simple blood test analyzing platelet activity could predict Alzheimer’s disease risk decades before symptoms. Published in Neurology, the research found a link between midlife platelet aggregation and the buildup of amyloid and tau proteins in the brain, particularly in individuals with lower platelet activity. This finding highlights the strong connection between vascular health and Alzheimer’s, potentially paving the way for personalized prevention strategies and new therapeutic targets focused on platelet-related inflammation.
11/10/2025
Bio-IT World
Watchmaker Genomics launched TAPS+, a next-generation technology uniting genetic and epigenetic readouts from the same DNA molecule for comprehensive tumor biology insights. Matija Snuderl, MD, Director of Molecular Pathology at NYU Langone Health, provided feedback, stating TAPS+ enables direct detection of 5mC alongside genetic drivers from challenging samples like FFPE or ctDNA. This unified workflow and improved chemistry deliver multimodal insight for precision oncology, advancing applications in cancer detection and therapy monitoring.
Also reporting was:
11/11/2025
News Medical
A new study led by John A. Dodson, MD, MPH, director of NYU Langone's Geriatric Cardiology Program and an associate professor in the Department of Medicine's Leon H. Charney Division of Cardiology at NYU Langone Health, found that financial incentives doubled medication adherence among high-risk, low-income individuals with high blood pressure. Presented at the American Heart Association's Scientific Sessions 2025, the BETTER-BP study involved 400 adults from New York City clinics. Despite improved adherence, participants did not achieve significantly better blood pressure control, and healthy habits reverted once incentives ceased, highlighting the complexity of behavior change.
11/11/2025
Medical Xpress
A new study reveals how estrogen influences learning and decision-making by boosting dopamine activity in the brain's reward center. Research by Christine Constantinople, PhD, professor in NYU Langone's Center for Neural Science, and Carla Golden, an NYU postdoctoral fellow, found neurological mechanisms fluctuate over the female reproductive cycle. The study, which also involved researchers from NYU Grossman School of Medicine's Neuroscience Institute, suggests increased estrogen enhances learning, while suppressed estrogen diminishes it, potentially linking hormone levels to neuropsychiatric disorder symptoms.
Also reporting was:
11/11/2025
Pittsburgh Post-Gazette
In a special to the Post-Gazette, Kelly McKinney, vice president of emergency management and enterprise resilience at NYU Langone Health, argues that U.S. presidents are dangerously unprepared for a "launch under attack" nuclear scenario. The author explains that the unimaginable stress of such a moment shuts down rational thought, making practice essential. McKinney calls for Congress to mandate full-immersion nuclear strike drills for every president-elect, noting that no president has participated in one since 1977. To highlight the absurdity of this lack of preparation, the author makes a direct comparison to the medical field, stating, "No surgeon operates without practice," yet presidents are entrusted with the fate of civilization without a single rehearsal.
11/05/2025
